An Analysis of Clinico-radiological Features and Outcome in Patients with Longitudinally Extensive Transverse

Karthik Thamarai Kannan1, Madhavi Karri1, Balakrishnan Ramasamy1

  • 1Department of Neurology, PSG Institute of Medical Sciences and Research, Coimbatore, Tamil Nadu, India.

Neurology India
|November 10, 2022
PubMed
Abstract

Insights

Longitudinally extensive transverse myelitis (LETM) is often caused by NMOSD, which typically shows good recovery. However, infective causes lead to poor neurological outcomes, and Ro-52 positivity indicates a risk of relapse.

Area of Science:

  • Neurology
  • Immunology
  • Neuroimmunology

Background:

  • Longitudinally extensive transverse myelitis (LETM) is an immune-mediated spinal cord disorder.
  • LETM can involve brain and optic nerve demyelination, with varied clinical, radiological, and treatment outcomes based on cause.
  • Understanding the diverse etiologies of LETM is crucial for effective management.

Purpose of the Study:

  • To investigate the various causes of LETM.
  • To compare clinicoradiological features and treatment outcomes across different LETM etiologies.
  • To identify prognostic factors for neurological recovery in LETM patients.

Main Methods:

  • Retrospective, single-center observational study of 42 LETM patients (2010-2019).
  • Analysis of clinical, radiological, CSF findings, treatment, and neurological status (EDMUS scoring).
  • Comparison of outcomes based on etiology, including Neuromyelitis Optica Spectrum Disorder (NMOSD), idiopathic, connective tissue disease, and infective causes.

Main Results:

  • Female predominance observed (80%), highest in NMOSD (87%).
  • NMOSD was the most frequent cause (16 patients), followed by idiopathic (7), connective tissue disease (5), and infective (4).
  • Bladder/respiratory involvement linked to infective/systemic causes; extensive segment involvement to idiopathic cases. Ro-52 positivity correlated with relapses. NMOSD showed better outcomes.

Conclusions:

  • NMOSD is the leading cause of LETM, generally associated with good 6-month neurological recovery.
  • Infective etiologies of LETM are linked to poor neurological recovery.
  • NMOSD patients with Ro-52 antibodies experienced relapses despite immunosuppression, highlighting a need for targeted therapies.